Vovantis Laboratories
Loading...

Commercial Inquiry & Project RFP

Home Commercial Inquiry & RFP
Turnkey Collaboration

Partner With a Proven Global CDMO

From early-stage molecule feasibility in our DSIR-recognized research laboratories to high-volume commercial tableting in our automated Ranoli facilities, Vovantis delivers turnkey regulatory certainty.

DSIR-Recognized Formulation Science

Proprietary effervescent kinetics, dissolution acceleration, and taste-masking technologies.

Mega Scale Commercial Capacity

1.2+ Billion effervescent tablets, 800M+ solid oral tablets, and automated desiccant tube packaging.

Global Regulatory Filings

Full CTD and eCTD dossiers with stability Zone IVb testing and bioequivalence support.

Strict Bilateral NDA Protection

All proprietary formulation concepts, molecule data, target batch volumes, and commercial timelines shared through this portal are treated under strict confidentiality and non-disclosure standards.

RFP Submission Console

Submit Project Proposal

Specify your technical formulation parameters and target commercial volumes. Our Business Development team will respond within 24 business hours.

Select a formulation from the dropdown or type a custom API and press Enter to add.
Evaluation Workflow

What Happens After You Submit

Our streamlined technical assessment protocol ensures rapid project momentum and complete transparency.

1
NDA & Intake

Bilateral NDA execution and initial technical dossier review by our BD director within 24h.

2
Feasibility Report

R&D scientists evaluate stoichiometric compatibility, dissolution kinetics, and patent landscape.

3
Commercial Proposal

Detailed costing, batch MOQs, regulatory timeline, and packaging feasibility delivered.

4
Pilot Scale-Up

Lab trial batches, stability Zone IVb testing, and commercial manufacturing schedule.

Direct Executive BD Desk

Prefer a Direct Technical Consultation?

Speak directly with Dr. Kinjal A Vekariya or schedule an on-site cGMP audit at our Ranoli, Vadodara manufacturing campus.

24-Hour Proposal Turnaround Direct Principal Scientist Access Mutual NDA Prior to Review